Mangoceuticals, Inc. (MGRX)
- Previous Close
0.2984 - Open
0.2851 - Bid --
- Ask --
- Day's Range
0.2308 - 0.2900 - 52 Week Range
0.1430 - 1.1200 - Volume
7,500,620 - Avg. Volume
4,040,671 - Market Cap (intraday)
8.119M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
www.mangoceuticals.com3
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MGRX
View More
Performance Overview: MGRX
Trailing total returns as of 10/2/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MGRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MGRX
View MoreValuation Measures
Market Cap
8.92M
Enterprise Value
8.72M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.28
Price/Book (mrq)
0.65
Enterprise Value/Revenue
10.06
Enterprise Value/EBITDA
-0.51
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-57.51%
Return on Equity (ttm)
-108.44%
Revenue (ttm)
866.79k
Net Income Avi to Common (ttm)
-9.13M
Diluted EPS (ttm)
-0.4300
Balance Sheet and Cash Flow
Total Cash (mrq)
490.24k
Total Debt/Equity (mrq)
2.06%
Levered Free Cash Flow (ttm)
-2.16M
Company Insights: MGRX
MGRX does not have Company Insights